Media like using superficial number, NPAT dropped by 63%, won't mention underlying figures and outlook. The shorters just took the opportunity to push price down.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025